Patents by Inventor Stephan Jaeger

Stephan Jaeger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230415941
    Abstract: Disclosed to a method for operating a system for treating a plurality of containers, with the steps: providing at least one container which has an ID, by which the container can be uniquely identified, wherein an identifier can be assigned to the ID, which identifier is stored in a memory device which is connected or can be connected to the system at least temporarily via a public network in order to communicate data; treating the container with a treatment apparatus of the system, collecting at least one data value with respect to the container and/or with respect to at least one treatment step of the container; and providing the at least one data value for transmission and/or storage in the memory device.
    Type: Application
    Filed: November 15, 2021
    Publication date: December 28, 2023
    Inventors: Ottmar AMANN, Stefan WENZL, Stephan JAEGER, Marcel STRICKROTH, Katarina MEHRINGER, Sandra BREITSCHAEDEL, Gerald HUETTNER
  • Patent number: 7462709
    Abstract: The present invention is directed to a method for the determination of a target nucleic acid using a special control nucleic acid, a method for the amplification of a partial sequence of said target nucleic acid using primers, a special control and a kit containing said control. The sequence of these control nucleic acids are at least in part parallel-complementary to the sequence of the target nucleic. These controls have similar properties as the target nucleic acid in hybridization and amplification methods, but can be well differentiated from the target nucleic acid by their different sequence.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: December 9, 2008
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Stephan Jaeger
  • Publication number: 20070117137
    Abstract: The present invention is directed to a method for the determination of a target nucleic acid using a special control nucleic acid, a method for the amplification of a partial sequence of said target nucleic acid using primers, a special control and a kit containing said control. The sequence of these control nucleic acids are at least in part parallel-complementary to the sequence of the target nucleic. These controls have similar properties as the target nucleic acid in hybridization and amplification methods, but can be well differentiated from the target nucleic acid by their different sequence.
    Type: Application
    Filed: December 20, 2006
    Publication date: May 24, 2007
    Applicant: Roche Molecular Systems, Inc.
    Inventor: Stephan Jaeger
  • Patent number: 7192745
    Abstract: The present invention is directed to a method for the determination of a target nucleic acid using a special control nucleic acid, a method for the amplification of a partial sequence of said target nucleic acid using primers, a special control and a kit containing said control. The sequence of these control nucleic acids are at least in part parallel-complementary to the sequence of the target nucleic. These controls have similar properties as the target nucleic acid in hybridization and amplification methods, but can be well differentiated from the target nucleic acid by their different sequence.
    Type: Grant
    Filed: March 1, 2002
    Date of Patent: March 20, 2007
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Stephan Jaeger
  • Patent number: 7183084
    Abstract: The present invention is directed to a method for the determination of a target nucleic acid using a special control nucleic acid, a method for the amplification of a partial sequence of said target nucleic acid using primers, a special control and a kit containing said control. The sequence of these control nucleic acids are at least in part parallel-complementary to the sequence of the target nucleic. These controls have similar properties as the target nucleic acid in hybridization and amplification methods, but can be well differentiated from the target nucleic acid by their different sequence.
    Type: Grant
    Filed: April 17, 2003
    Date of Patent: February 27, 2007
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Stephan Jaeger
  • Publication number: 20030165982
    Abstract: The present invention is directed to a method for the determination of a target nucleic acid using a special control nucleic acid, a method for the amplification of a partial sequence of said target nucleic acid using primers, a special control and a kit containing said control. The sequence of these control nucleic acids are at least in part parallel-complementary to the sequence of the target nucleic. These controls have similar properties as the target nucleic acid in hybridization and amplification methods, but can be well differentiated from the target nucleic acid by their different sequence.
    Type: Application
    Filed: April 17, 2003
    Publication date: September 4, 2003
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventor: Stephan Jaeger
  • Publication number: 20030054372
    Abstract: The present invention is directed to a method for the determination of a target nucleic acid using a special control nucleic acid, a method for the amplification of a partial sequence of said target nucleic acid using primers, a special control and a kit containing said control. The sequence of these control nucleic acids are at least in part parallel-complementary to the sequence of the target nucleic. These controls have similar properties as the target nucleic acid in hybridization and amplification methods, but can be well differentiated from the target nucleic acid by their different sequence.
    Type: Application
    Filed: March 1, 2002
    Publication date: March 20, 2003
    Inventor: Stephan Jaeger
  • Patent number: 6248522
    Abstract: The invention concerns a method for the amplification of nucleic acids using a reagent which prevents reactivation of degradation enzymes. This enables a simpler prevention of contaminations.
    Type: Grant
    Filed: August 20, 1998
    Date of Patent: June 19, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Gerd Haberhausen, Stephan Jäger, Harald Sobek